A detailed history of Tudor Financial Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Tudor Financial Inc. holds 4,708 shares of ABT stock, worth $612,181. This represents 0.34% of its overall portfolio holdings.

Number of Shares
4,708
Previous 4,706 0.04%
Holding current value
$612,181
Previous $640 Million 1.49%
% of portfolio
0.34%
Previous 0.36%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$120.51 - $136.62 $241 - $273
2 Added 0.04%
4,708 $631 Million
Q2 2025

Aug 13, 2025

BUY
$123.95 - $138.08 $247 - $276
2 Added 0.04%
4,706 $640 Million
Q1 2025

Apr 16, 2025

BUY
$111.1 - $140.22 $111 - $140
1 Added 0.02%
4,704 $624 Million
Q4 2024

Jan 16, 2025

BUY
$111.93 - $119.39 $230,128 - $245,465
2,056 Added 77.67%
4,703 $532 Million
Q3 2024

Nov 21, 2024

BUY
$100.07 - $118.13 $264,885 - $312,690
2,647 New
2,647 $302 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Tudor Financial Inc. Portfolio

Follow Tudor Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tudor Financial Inc. with notifications on news.